Clinical Trials Logo
  1. Home
  2. Asthma
  3. NCT03120481
  4. Details
NCT03120481 Clinical Trial

Controls for Respiratory Diseases

Asthma Clinical Trial

Official title:
The Registry of Controls for Respiratory Diseases

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03120481
Other study ID # 2016-3435
Secondary ID
Status Recruiting
Phase N/A
First received April 14, 2017
Last updated April 14, 2017
Start date April 10, 2017
Est. completion date February 28, 2037

Study information
Verified date April 2017
Source Seoul National University Hospital
Contact Chang-Hoon Lee, M.D.
Phone 82-2-2072-4743
Email kauri670@gmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This is the registry of control participants for patients with various respiratory diseases. We screened healthy volunteers who visited Seoul National Hospital Healthcare System Gangnam Center for routine health check-up, and enrolled patients who agree to participate in the study. The participants undergo baseline questionnaires, provide blood specimen and information of the results of health check-up. We will include participants as controls if they have no significant respiratory symptom and no significant radiographic abnormality. The data from this registry will be compared with those from other registry of various respiratory diseases

Recruitment information / eligibility
Status Recruiting
Enrollment 1572
Est. completion date February 28, 2037
Est. primary completion date February 28, 2037
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 90 Years
Eligibility Inclusion Criteria:

- 19-90 years old male and female

- underwent health check-up including chest radiography

- obtained informed consent

Exclusion Criteria:

- those who showed a significant abnormal finding of chest radiography

- those who reported a significant respiratory symptoms

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• no intervation
no intervention

Locations
Country Name City State
Korea, Republic of Seoul National University Healthcare System Gangnam Center Seoul

Sponsors (1)
Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Mortality Death 20 years
Secondary Hospitalization All cause hospitalization 20 years
Secondary Respiratory hospitalization Hospitalization from respiratory causes 20 years
Secondary Respiratory diseases diagnosis Respiratory diseases diagnosis 20 years
See also
  Status Clinical Trial Phase
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device